S&P 500   4,071.70 (-0.12%)
DOW   34,429.88 (+0.10%)
QQQ   292.55 (-0.40%)
AAPL   147.81 (-0.34%)
MSFT   255.02 (+0.13%)
META   123.49 (+2.53%)
GOOGL   100.44 (-0.54%)
AMZN   94.13 (-1.43%)
TSLA   194.86 (+0.08%)
NVDA   168.76 (-1.51%)
NIO   13.13 (+8.60%)
BABA   90.06 (+4.79%)
AMD   74.98 (-3.23%)
T   19.02 (-0.89%)
MU   54.68 (-1.46%)
CGC   4.29 (+9.16%)
F   13.86 (-1.56%)
GE   86.88 (+1.90%)
DIS   99.43 (+0.85%)
AMC   8.17 (+0.00%)
PYPL   74.66 (-4.93%)
PFE   50.91 (-0.33%)
NFLX   320.41 (+1.09%)
S&P 500   4,071.70 (-0.12%)
DOW   34,429.88 (+0.10%)
QQQ   292.55 (-0.40%)
AAPL   147.81 (-0.34%)
MSFT   255.02 (+0.13%)
META   123.49 (+2.53%)
GOOGL   100.44 (-0.54%)
AMZN   94.13 (-1.43%)
TSLA   194.86 (+0.08%)
NVDA   168.76 (-1.51%)
NIO   13.13 (+8.60%)
BABA   90.06 (+4.79%)
AMD   74.98 (-3.23%)
T   19.02 (-0.89%)
MU   54.68 (-1.46%)
CGC   4.29 (+9.16%)
F   13.86 (-1.56%)
GE   86.88 (+1.90%)
DIS   99.43 (+0.85%)
AMC   8.17 (+0.00%)
PYPL   74.66 (-4.93%)
PFE   50.91 (-0.33%)
NFLX   320.41 (+1.09%)
S&P 500   4,071.70 (-0.12%)
DOW   34,429.88 (+0.10%)
QQQ   292.55 (-0.40%)
AAPL   147.81 (-0.34%)
MSFT   255.02 (+0.13%)
META   123.49 (+2.53%)
GOOGL   100.44 (-0.54%)
AMZN   94.13 (-1.43%)
TSLA   194.86 (+0.08%)
NVDA   168.76 (-1.51%)
NIO   13.13 (+8.60%)
BABA   90.06 (+4.79%)
AMD   74.98 (-3.23%)
T   19.02 (-0.89%)
MU   54.68 (-1.46%)
CGC   4.29 (+9.16%)
F   13.86 (-1.56%)
GE   86.88 (+1.90%)
DIS   99.43 (+0.85%)
AMC   8.17 (+0.00%)
PYPL   74.66 (-4.93%)
PFE   50.91 (-0.33%)
NFLX   320.41 (+1.09%)
S&P 500   4,071.70 (-0.12%)
DOW   34,429.88 (+0.10%)
QQQ   292.55 (-0.40%)
AAPL   147.81 (-0.34%)
MSFT   255.02 (+0.13%)
META   123.49 (+2.53%)
GOOGL   100.44 (-0.54%)
AMZN   94.13 (-1.43%)
TSLA   194.86 (+0.08%)
NVDA   168.76 (-1.51%)
NIO   13.13 (+8.60%)
BABA   90.06 (+4.79%)
AMD   74.98 (-3.23%)
T   19.02 (-0.89%)
MU   54.68 (-1.46%)
CGC   4.29 (+9.16%)
F   13.86 (-1.56%)
GE   86.88 (+1.90%)
DIS   99.43 (+0.85%)
AMC   8.17 (+0.00%)
PYPL   74.66 (-4.93%)
PFE   50.91 (-0.33%)
NFLX   320.41 (+1.09%)
LON:GSK

GSK - GSK Share Forecast, Price & News

GBX 1,423.80
+8.40 (+0.59%)
(As of 12/2/2022 04:45 PM ET)
Add
Compare
Today's Range
1,401.20
1,427.60
50-Day Range
1,305.80
1,448
52-Week Range
1,280.92
1,824.40
Volume
6.06 million shs
Average Volume
8.63 million shs
Market Capitalization
£57.91 billion
P/E Ratio
1,306.24
Dividend Yield
5.39%
Price Target
GBX 1,622

GSK MarketRank™ Forecast

Analyst Rating
Hold
2.44 Rating Score
Upside/​Downside
13.9% Upside
GBX 1,622 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.56
Upright™ Environmental Score
News Sentiment
0.17mentions of GSK in the last 14 days
Based on 8 Articles This Week
Insider Trading
Acquiring Shares
£4.29 M Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.19 out of 5 stars

GSK stock logo

About GSK (LON:GSK) Stock

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Receive GSK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

GSK Stock News Headlines

GSK's (GSK) Buy Rating Reaffirmed at Shore Capital
GSK Plc Gets a Belated Fundamental Downgrade
GSK (GSK) Q3 Earnings and Revenues Beat Estimates
See More Headlines
Receive GSK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

GSK Company Calendar

Last Earnings
7/29/2020
Ex-Dividend for 10/6 Dividend
8/18/2022
Dividend Payable
10/06/2022
Ex-Dividend for 1/12 Dividend
11/17/2022
Today
12/02/2022
Dividend Payable
1/12/2023
Next Earnings (Estimated)
2/01/2023

Industry, Sector and Symbol

Industry
Drug Manufacturers - Major
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
90,096
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 1,622
High Stock Price Forecast
GBX 2,000
Low Stock Price Forecast
GBX 1,300
Forecasted Upside/Downside
+13.9%
Consensus Rating
Hold
Rating Score (0-4)
2.44
Research Coverage
9 Analysts

Profitability

P/E Growth
7781.36
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£38.44 billion
Cash Flow
GBX 178.55 per share
Book Value
GBX 226.90 per share

Miscellaneous

Outstanding Shares
4,067,388,000
Free Float
N/A
Market Cap
£57.91 billion
Optionable
Optionable
Beta
N/A

Key Executives

  • Ms. Emma Natasha Walmsley (Age 52)
    CEO & Director
    Comp: $3.88M
  • Mr. Iain James Mackay (Age 60)
    CFO & Exec. Director
    Comp: $2.88M
  • Ms. Julie Brown (Age 60)
    Chief Financial Officer
  • Ms. Shobie Ramakrishnan
    Chief Digital & Technology Officer
  • Mr. Tony Wood
    Chief Scientific Officer
  • Ms. Sarah Elton-Farr
    Head of Investor Relations
  • Mr. James Ford
    Sr. VP & Group Gen. Counsel of Legal & Compliance
  • Ms. Sally Jackson
    Sr. VP of Global Communications & CEO Office
  • Ms. Diana Conrad
    Chief People Officer
  • Mr. David Simon Redfern (Age 56)
    Chief Strategy Officer













GSK Stock - Frequently Asked Questions

Should I buy or sell GSK stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for GSK in the last year. There are currently 5 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" GSK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GSK, but not buy additional shares or sell existing shares.
View GSK analyst ratings
or view top-rated stocks.

What is GSK's stock price forecast for 2023?

9 Wall Street research analysts have issued 1 year target prices for GSK's shares. Their GSK share price forecasts range from GBX 1,300 to GBX 2,000. On average, they anticipate the company's stock price to reach GBX 1,622 in the next twelve months. This suggests a possible upside of 13.9% from the stock's current price.
View analysts price targets for GSK
or view top-rated stocks among Wall Street analysts.

How have GSK shares performed in 2022?

GSK's stock was trading at GBX 1,606.60 at the start of the year. Since then, GSK shares have decreased by 11.4% and is now trading at GBX 1,423.80.
View the best growth stocks for 2022 here
.

When is GSK's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 1st 2023.
View our GSK earnings forecast
.

How were GSK's earnings last quarter?

GSK plc (LON:GSK) announced its quarterly earnings data on Wednesday, July, 29th. The company reported $56.90 earnings per share for the quarter.

How often does GSK pay dividends? What is the dividend yield for GSK?

GSK announced a dividend on Wednesday, November 2nd. Investors of record on Thursday, November 17th will be paid a dividend of GBX 13.75 per share on Thursday, January 12th. This represents a yield of 0.95%. The ex-dividend date is Thursday, November 17th. The official announcement can be viewed at this link.
Read our dividend analysis for GSK
.

Is GSK a good dividend stock?

GSK (LON:GSK) pays an annual dividend of GBX 0.86 per share and currently has a dividend yield of 5.39%. GSK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 79.13%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for GSK.

What other stocks do shareholders of GSK own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GSK investors own include AstraZeneca (AZN), General Electric (GE), Royal Dutch Shell (RDSB), Vodafone Group Public (VOD), Intel (INTC), NVIDIA (NVDA), Johnson & Johnson (JNJ), AT&T (T), Barclays (BARC) and Gilead Sciences (GILD).

What is GSK's stock symbol?

GSK trades on the London Stock Exchange (LON) under the ticker symbol "GSK."

How do I buy shares of GSK?

Shares of GSK stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is GSK's stock price today?

One share of GSK stock can currently be purchased for approximately GBX 1,423.80.

How much money does GSK make?

GSK (LON:GSK) has a market capitalization of £57.91 billion and generates £38.44 billion in revenue each year.

How many employees does GSK have?

The company employs 90,096 workers across the globe.

How can I contact GSK?

GSK's mailing address is 980 Great West Road, BRENTFORD, TW8 9GS, United Kingdom. The official website for the company is www.gsk.com. The company can be reached via phone at +44-20-80475000.

This page (LON:GSK) was last updated on 12/2/2022 by MarketBeat.com Staff